1 Other endpoints were
post hoc.
2 ased on adverse event reporting was analysed
post hoc.
3 ted the double-blind phase of the trial were
post-hoc.
4 (P=0.03 in unadjusted analyses; P=0.39 after
post hoc adjustment for multiple secondary outcomes).
5 than error rates obtained when using (i) no
post-hoc adjustment, (ii) a Bonferroni adjustment and (i
6 e. Type I or II) and eliminates the need for
post-hoc adjustments.
7 multiple "peeks" at the data, and unplanned,
post hoc analyses (i.e., "data dredging," "fishing exped
8 In
post hoc analyses among female never smokers, both PM2.5
9 Post hoc analyses established that PdE concentration inc
10 The
post hoc analyses examined the relationship of neural ab
11 Importance:
Post hoc analyses from the Diabetic Retinopathy Clinical
12 We performed
post hoc analyses from the WOSCOPS (West of Scotland Cor
13 Post hoc analyses in patients who tolerated GDMT were al
14 Post hoc analyses included voxel-based morphometry and d
15 These
post hoc analyses indicate that patients with severe eos
16 Post hoc analyses indicated interactions between the int
17 Post hoc analyses of associations to psychosis symptoms
18 Post hoc analyses of HYVET suggested that active hyperte
19 Recent
post hoc analyses of several clinical trials with P2Y12
20 Six
post hoc analyses of the previously published Hypertensi
21 Post hoc analyses of the structural tractography pattern
22 Design, Setting, and Participants:
Post hoc analyses performed from May 3, 2016, to June 21
23 Post hoc analyses provided weak evidence of increased mo
24 The
post hoc analyses revealed that in the dorsal mid-insula
25 Post hoc analyses revealed that OB individuals exhibited
26 Conclusions and Relevance: Although
post hoc analyses should be viewed with caution given th
27 Post hoc analyses stratified patients with FND by mental
28 RATIONALE:
Post hoc analyses suggest that blood eosinophils have po
29 The VICTOR biobank was used in a series of
post hoc analyses that yielded unique and clinically val
30 We performed
post hoc analyses to evaluate the effect of humanized mo
31 Subsequent
post hoc analyses were conducted to address further cuto
32 Results:
Post hoc analyses were performed for 660 participants (m
33 Post hoc analyses were performed to explore the possible
34 ical vs surrogate primary end points, use of
post hoc analyses, and reporting of age and sex.
35 In
post hoc analyses, significant differences in favor of a
36 In planned
post hoc analyses, the authors examined associations bet
37 In
post hoc analyses, the effect of treatment seemed to be
38 In
post hoc analyses, VM CPM and time spent in moderate/vig
39 In
post hoc analyses, we aimed to identify associations bet
40 In
post hoc analyses, we assessed changes in invasive coron
41 roblems of publication bias and questionable
post hoc analyses.
42 alyzed via analysis of variance and Fisher's
post hoc analyses.
43 Observational data and results from
post-hoc analyses in clinical trials suggest that direct
44 Post-hoc analyses indicated that effects were not signif
45 Post-hoc analyses of an open cohort from an observationa
46 Epidemiological studies and
post-hoc analyses of clinical trials of corticosteroid t
47 In
post-hoc analyses of patients with nonalcoholic fatty li
48 evels of <4 or <6 million (M) IU/mL based on
post-hoc analyses of phase 3 trial data.
49 Post-hoc analyses revealed that the glutamine/glutamate
50 dition and competency of advisor and further
post-hoc analyses revealed that this effect was more pro
51 Although the VHS had no overall effect,
post-hoc analyses suggest VHS might be effective in redu
52 In
post-hoc analyses, 5-year progression-free survival was
53 er); the effect of crossover was assessed in
post-hoc analyses, in which responses achieved after cro
54 hospital admission for heart failure in the
post hoc analysis (HR 1.00, 95% CI 0.82-1.21) and result
55 c treatment was determined at 215.5 mum in a
post hoc analysis (sensitivity 62.5 %, specificity 96.4
56 The present
post hoc analysis assessed the end point of all-cause mo
57 This
post hoc analysis evaluated the influence of select base
58 This
post hoc analysis examined potential interaction between
59 This
post hoc analysis examined whether the effects of the SB
60 A
post hoc analysis exploring the effect of atrophy in the
61 by using a one-way analysis of variance with
post hoc analysis for statistically significant differen
62 A
post hoc analysis for the primary end point considering
63 In a
post hoc analysis from 10 ODYSSEY trials, greater percen
64 Here, in a
post hoc analysis in 1147 patients with type 2 diabetes
65 We also performed a
post hoc analysis in which the rates of major complicati
66 view is meant to allow readers to appreciate
post hoc analysis not as an entity with a single approac
67 Post hoc analysis of (68)Ga-PSMA-11 PET/CT implied a maj
68 evidence from 1 RCT of 21 162 patients and a
post hoc analysis of 1 RCT of 15 603 patients to answer:
69 This was a
post hoc analysis of 130 prospectively included patients
70 Post hoc analysis of 2 prospectively followed up pediatr
71 We undertook a
post hoc analysis of 2 randomized clinical trials evalua
72 Post hoc analysis of 2 similarly designed phase 3 trials
73 This
post hoc analysis of a clinical trial assessed the medic
74 This investigation was a
post hoc analysis of a cohort in the e-ROP Study (a mult
75 We performed a
post hoc analysis of a phase III placebo-controlled stud
76 tion on the outcome of 30-day mortality in a
post hoc analysis of a prospective cohort study of patie
77 In this
post hoc analysis of a randomized clinical trial which t
78 We performed a
post hoc analysis of a randomized controlled trial of no
79 ed for treatment of endovascular stroke in a
post hoc analysis of a recent randomized controlled tria
80 , and Participants: This investigation was a
post hoc analysis of a subgroup of laser control eyes in
81 This investigation was a
post hoc analysis of a subgroup of laser control eyes in
82 This was a
post hoc analysis of an intention-to-treat population of
83 A meta-analysis and a
post hoc analysis of an RCT in patients with stable card
84 In a
post hoc analysis of children weighing 65 kg or less, th
85 Post hoc analysis of clinical and laboratory features co
86 A
post hoc analysis of clinical trials of adults with acti
87 l Coherence Tomography, seems to emerge from
post hoc analysis of collected data demonstrating strong
88 We performed a
post hoc analysis of data from a phase 2 trial to assess
89 In a
post hoc analysis of data from a phase III study of the
90 ional review board approval was obtained for
post hoc analysis of data from a prospective single-cent
91 Post hoc analysis of data from the 36-month prospective,
92 Post hoc analysis of efficacy, safety, and resource util
93 We conducted a
post hoc analysis of HF-related MACE (HF hospitalization
94 A
post hoc analysis of Medicare Part D data revealed low p
95 An exploratory
post hoc analysis of participants with a consistent rate
96 In a
post hoc analysis of patients with an initially abnormal
97 Post hoc analysis of prospectively collected data.
98 In this
post hoc analysis of ROSE AHF, the response to vasoactiv
99 In a
post hoc analysis of subjects with an estimated glomerul
100 or BITA grafts and outcomes by performing a
post hoc analysis of the ART.
101 We performed a
post hoc analysis of the Assessment of Dual Antiplatelet
102 In this
post hoc analysis of the DEFUSE 2 study, 35 patients wit
103 CKD progression in children, we performed a
post hoc analysis of the Effect of Strict Blood Pressure
104 We conducted a
post hoc analysis of the Folic Acid for Vascular Outcome
105 This secondary
post hoc analysis of the MAGIC trial included participan
106 nostic factor for overall survival (OS) in a
post hoc analysis of the Mainsail trial.
107 We performed a
post hoc analysis of the METOCARD-CNIC (effect of METOpr
108 Post hoc analysis of the multicenter TTM-trial.
109 unication in advanced cancer, we conducted a
post hoc analysis of the patient intervention component,
110 This is a
post hoc analysis of the PermiT (Permissive Underfeeding
111 Moreover, a
post hoc analysis of the phase 2 trial of NP001 using th
112 Post hoc analysis of the phase III RIDE and RISE studies
113 This is a
post hoc analysis of the RE-LY trial.
114 uncontrolled retrospective case series and a
post hoc analysis of the registration trial for temozolo
115 In this
post hoc analysis of the Singapore Epidemiology of Eye D
116 Cross-sectional
post hoc analysis of the Singapore Epidemiology of Eye D
117 Conclusion This
post hoc analysis of the single-center SIESTA trial reve
118 weight and follow-up visits and performed a
post hoc analysis of the Treating to New Targets trial,
119 A
post hoc analysis of the VISUAL-1 and VISUAL-2 placebo-c
120 We here report a
post hoc analysis of this trial after a median follow-up
121 We report a
post hoc analysis of this trial after a median follow-up
122 A
post hoc analysis revealed a more complex picture where
123 This
post hoc analysis reveals that treatment with denosumab
124 roflumilast improved lung function, and in a
post hoc analysis roflumilast significantly reduced the
125 Post hoc analysis showed that KOM had higher SBP than KO
126 A
post hoc analysis showed that this association reflected
127 noninferiority analysis was indeterminate, a
post hoc analysis suggested that VA improvement with thi
128 This
post hoc analysis suggests that adalimumab is associated
129 We conducted a
post hoc analysis to assess the effect of coadministrati
130 A
post hoc analysis to discern sources of inter-individual
131 We conducted a
post hoc analysis to explore the potential efficacy of s
132 This
post hoc analysis used data from 291 patients treated wi
133 CI, 10% to 37%) by Kaplan-Meier estimate in
post hoc analysis using definitions and methods consiste
134 CI, 7% to 26%) by Kaplan-Meier estimate in a
post hoc analysis using methods consistent with historic
135 This exploratory
post hoc analysis was conducted between October 1, 2011,
136 was conducted from 1998 to 2006; the present
post hoc analysis was conducted from March 1, 2014, to M
137 Post hoc analysis was conducted of prospectively collect
138 A
post hoc analysis was performed for delayed anemia, defi
139 A
post hoc analysis was performed of 496 patients enrolled
140 Post hoc analysis was performed of a previously conducte
141 A
post hoc analysis was performed of the Efficacy of Vasop
142 A
post hoc analysis was performed of the phase 2 trial of
143 A
post hoc analysis was performed to assess whether these
144 We performed an exploratory,
post hoc analysis with 1255 participants (677 men and 57
145 for each dose vs placebo group comparison in
post hoc analysis).
146 In a
post hoc analysis, 192/885 (22%) children developed dela
147 In a
post hoc analysis, a cut-off value of CFT for systemic t
148 In addition, from
post hoc analysis, a greater proportion of brolucizumab-
149 Post hoc analysis, between-study differences in patient
150 In
post hoc analysis, clinic visits significantly increased
151 In a
post hoc analysis, higher rates of HIV-1 protection were
152 However, in a
post hoc analysis, losartan was associated with improved
153 In this
post hoc analysis, patients with a GRACE score >140 were
154 In
post hoc analysis, right ventricular stroke volume incre
155 In a
post hoc analysis, stent length was the only subgroup of
156 In a
post hoc analysis, the 2-year cumulative incidence of he
157 In a
post hoc analysis, the proportion of IFN-switch patients
158 In a
post hoc analysis, the rate of major adverse cardiovascu
159 In a
post hoc analysis, the relationship between average on-t
160 In a
post hoc analysis, there was strong evidence that solar
161 In
post hoc analysis, video laryngoscopy was associated wit
162 In a
post hoc analysis, we also compared results to the EFS r
163 In a
post hoc analysis, we also compared TSPO availability be
164 In this
post hoc analysis, we investigated the relationship betw
165 In a
post hoc analysis, we performed a cross-sectional observ
166 In this
post hoc analysis, weight change at 12 and 24 months was
167 h specificity (87%) and sensitivity (78%) in
post hoc analysis.
168 s intermediate between the two groups in the
post hoc analysis.
169 We did a
post-hoc analysis after complete ICS withdrawal (months
170 e interval: 1.02-5.24; P = .045), based on a
post-hoc analysis for the modified definition.
171 Post-hoc analysis of a prospective clinical study.
172 Post-hoc analysis of all CYD14/15 trial participants rev
173 A
post-hoc analysis of data from trial of patients with NA
174 We did a
post-hoc analysis of data from two replicate, randomised
175 We did a
post-hoc analysis of data, which was completed on Sept 2
176 ied subgroup analysis in August, 2013, and a
post-hoc analysis of non-inferiority and safety in March
177 Post-hoc analysis of survival to combined endpoint in SM
178 We did a
post-hoc analysis of the 3 year inhaled Steroid Treatmen
179 In a
post-hoc analysis of the PARADIGM-HF trial, we included
180 However, in a
post-hoc analysis of the primary endpoint, the within-tr
181 This is a retrospective
post-hoc analysis of the YELLOW II trial, comparing pati
182 Post-hoc analysis revealed that the effect of DRS model
183 Post-hoc analysis showed that the T1/2 of gastric emptyi
184 Post-hoc analysis with Bonferroni correction revealed th
185 In this
post-hoc analysis, Cap-assisted colonoscopy is a safe te
186 In a
post-hoc analysis, mean reductions in LDL cholesterol in
187 In a
post-hoc analysis, rates of patients with inappropriate
188 In a
post-hoc analysis, reduction of mortality was more evide
189 In a
post-hoc analysis, we also investigated the effects on g
190 In this
post-hoc analysis, we analysed complete clinical respons
191 In a
post-hoc analysis, we analysed survival at 7 days after
192 In a
post-hoc analysis, we found difference in blood pressure
193 In this
post-hoc analysis, we test the hypothesis that the overa
194 In this
post-hoc analysis, we used prospectively collected data
195 o- or hyper-methylated locus without further
post-hoc analysis.
196 ACITY 006, and ASCEND) were included in this
post-hoc analysis.
197 ients with a history of cancer were reviewed
post hoc and categorised according to the presence or ab
198 Analyses were
post hoc,
and the results are only generalizable to knee
199 This
post hoc ART analysis showed that an additional RA was a
200 ysis of variance or Kruskal-Wallis test with
post hoc Bonferroni correction was used.
201 lyzed using analysis of variance followed by
post hoc Bonferroni correction.
202 ariance, followed by the Student t test with
post hoc Bonferroni correction.
203 lysis of variance for repeated measures with
post hoc Bonferroni correction.
204 repeated measures analysis of variance and a
post hoc Bonferroni multiple comparison test.
205 One-way ANOVA with the
post hoc Bonferroni test was used for group comparison,
206 were analyzed by repeated measures ANOVA and
post hoc Bonferroni test.A total of 19 patients [aged 65
207 redicted; instead, response is only assessed
post hoc by physical examination or imaging methods.
208 Nettle et al.'s findings could be explained,
post hoc,
by each of these accounts, suggesting that the
209 uracy emphasizes the importance of effective
post-hoc calculation of area sampled or use of methods t
210 acing, whole-cell patch-clamp recordings and
post hoc cell type identification, we found that leptin
211 this combined outcome and of death alone in
post hoc combined analyses.
212 In
post hoc combined, unadjusted analyses that included all
213 A
post hoc comparison found that at month 12, the differen
214 Post hoc comparisons of cognition, adaptive functioning,
215 statistically significant differences after
post hoc correction (alpha = 0.05) were found among VBD
216 is of variance and Mann-Whitney U tests with
post hoc correction were used to assess differences in a
217 n and analysis of variance with Tukey-Kramer
post hoc correction were used to compare the multimodali
218 Post hoc design and data analysis were performed between
219 vel baseline differences in performance, the
post-hoc determination of age moderation, and potential
220 0-10.2%), versus no patient (0 of 23) with a
post hoc-
determined elevated NT-proBNP level from the di
221 was written cannot be determined directly by
post-hoc DNA sequencing; the timing data must be estimat
222 f significant differences were revealed, the
POST-HOC Duncan test was used (alpha=0.05).
223 analyses, Kruskal-Wallis rank sum test, and
post hoc Dunn test with Holm correction.
224 Post hoc exploratory analyses were conducted of randomiz
225 This was a
post hoc exploratory analysis of the randomized, open-la
226 A
post hoc exploratory analysis suggested that ALDHbr cell
227 In
post-hoc exploratory analyses of UTIs with higher bacter
228 We performed
post hoc,
exploratory analyses of a randomized clinical
229 -tracking: -28.7 +/- 4.8%) (ANOVA with Tukey
post-hoc,
F-value 279.93, p < 0.01).
230 Post hoc falsification end point analyses were performed
231 Linear mixed models with a
post hoc Fisher least significant difference test were u
232 cer mortality were found, but the results of
post hoc high-risk subgroup analyses showed nonsignifica
233 Post hoc identification of labeled cells showed that (fa
234 subgrouping is found, we present methods for
post hoc identification of the contributing genetic vari
235 Post-hoc immunohistochemistry was used to confirm cell i
236 s, and all statistical comparisons were done
post hoc in this interim analysis.
237 minating process of a decision rather than a
post hoc inference or arbitrary report.
238 these deficits were abolished by transient,
post hoc interference with the chromatin binding of the
239 ys for testing), enabling the most extensive
post hoc investigation into seizure forecasting.
240 , the rate of LFN amplitude change predicted
post-hoc learning outcome measures.
241 s analysis of variance (ANOVA)-on-Ranks with
post-hoc Mann-Whitney U-tests showed significant pairwis
242 Post-hoc matching of cases and controls yielded 362 case
243 Post hoc measures for phenotypes related to suicide risk
244 Exploratory
post hoc meta-analysis showed a statistically significan
245 In this
post-hoc meta-analysis, we investigate whether a 2% thre
246 A
post hoc multivariable analysis identified pre-existing
247 tion, and there were significant findings in
post hoc multivariable and on-treatment analyses.
248 tively small sample size (3 studies) and its
post-hoc nature, it provides additional new evidence for
249 In a
post hoc,
nonrandomized analysis from the FREEDOM (Futur
250 analyses, with the exception of patients who
post-hoc objectively did not meet the eligibility criter
251 In this analysis of prespecified and
post hoc objectives from the trial, we compared signs an
252 ry outcome measure and population, ROCKET-1,
post hoc outcome measure). was also noninferior to timol
253 ort secondary outcome data for fractures and
post-hoc outcome data for falls.
254 compared with all other treatments (Tukey's
post hoc,
P < 0.05).Macronutrient delivery to the proxim
255 food compared with saline-to-ileum (Tukey's
post hoc,
P < 0.05); decreased ad libitum EI at lunch co
256 22%, -988 +/- 379 kJ (mean +/- SEM), Tukey's
post hoc,
P < 0.05]; and increased glucagon-like peptide
257 d measures one-way analysis of variance with
post hoc pair-wise comparisons.
258 These data were further processed with
post-hoc pair-wise comparisons.
259 cotype DX test recurrence score (ODxRS), and
post hoc pairwise comparisons assessed ODxRS means by us
260 A
post hoc per protocol analysis of SVR was performed on p
261 = .05), although this was not confirmed in a
post hoc plasma anti-AD-2 IgG blocking assay.
262 We also did
post-hoc regression analysis and subgroup analysis of ch
263 A
post hoc removal of machine learning models that perform
264 Design, Setting, and Participants: A
post hoc,
retrospective analysis was performed using dat
265 review types using analysis of variance and
post hoc Scheffe tests after achieving normally distribu
266 e predominant reason for requesting data was
post hoc secondary analysis of new questions (72%), foll
267 These
post hoc secondary findings suggest that for eyes with b
268 Results of
post-hoc seed-based correlation analyses further strengt
269 3% of subjects given placebo (P = .05 in the
post hoc sensitivity analysis).
270 Alternatively,
post hoc staining of immediate early genes (IEGs) indica
271 In addition,
post hoc stratification of data obtained from a clinical
272 This
post hoc study of 3 large multicenter trials involving 2
273 The objective of this
post hoc study was to evaluate the impact of number of d
274 In this
post hoc study, a highly significant reduction in HPV pr
275 We conducted a
post hoc subgroup analysis of patients with honeycombing
276 In
post hoc subgroup analysis, cohorts receiving more than
277 orticosteroids, or end-study 25(OH)D levels;
post-hoc subgroup analyses were done according to sex an
278 Post-hoc subgroup and sensitivity analyses showed that o
279 Non-inferiority (p=8.82 x 10(-16)) and
post-hoc superiority (p=0.023) were met.
280 Post hoc t tests showed reduced fractional anisotropy in
281 a mixed linear model approach and subsequent
post hoc t tests.
282 parisons were performed using the Bonferroni
post hoc test (P <0.05).
283 Paired t test and Friedman test with Dunn's
post hoc test for multiple comparisons were used for sta
284 ed to two-way analysis of variance and Tukey
post hoc test with P < 0.05.
285 chi(2) test was performed (Haberman
post hoc test).
286 Regardless of tinnitus laterality,
post hoc testing indicated reductions that were signific
287 were analyzed using analysis of variance and
post hoc tests (significance level 0.05).
288 terms of treatment by time interactions and
post hoc tests at 1 or more individual time points.
289 Post hoc tests identified a significantly greater high-c
290 Pairwise
post hoc tests were conducted using the Mann-Whitney U t
291 lysis of variance was performed, followed by
post hoc tests with Bonferroni correction, to assess the
292 roni and Tukey honest significant difference
post hoc tests.
293 ed using analysis of variance and Bonferroni
post hoc tests.
294 Post-hoc tests showed that CCRT but not TAU significantl
295 Post-hoc tests showed that there was significant increas
296 repeated measures including prespecified and
post-hoc tests.
297 reatinine clearance >30 ml/min) and examined
post hoc the relationship of eGFR with end points across
298 tudies in humans and animal models show that
post hoc treatment strategies do not reliably prevent ID
299 rd deviation; 1-way analysis of variance and
post hoc Tukey's studentized range test were used for co
300 An exploratory
post hoc whole-brain analysis also indicated that SCD wa